4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-22-003374
Options or other derivatives
- EXECUTIVE CHAIRMAN OF BOARD acquired 107,805 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Jaksch Frank L Jr · EXECUTIVE CHAIRMAN OF BOARD
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-17 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +107,805 | 107,805 | D |
Loading xslF345X03/wf-form4_164556903170946.xml…